INSMED Inc (INSM) income statement
INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3099% above fair value
$119.80−2.06 (-1.69%)
Close on Nov 18, 2026Market cap $26.28BP/E –Yield –
INSMED Inc income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 84.4%
- Operating margin
- -37.1%
- Net margin
- -39.9%
- Return on equity, FY2025
- -249.3%
Financial strength
- Current ratio
- 2.86
- Debt to equity
- 0.76
- Debt to assets
- 24.9%
- Cash to current liabilities
- 66.5%
Valuation
- P/E ratio
- –
- Price to sales
- 17.29
- Price to book
- 36.19
- Dividend yield
- –
See a number that looks wrong?